Vaccination in rheumatology: the present and prospects

Autor: Boris Sergeyevich Belov, G M Tarasova, M S Naumtseva

Publikováno v: Современная ревматология, Vol 0, Iss 3, Pp 15-22 (2012)

In modern rheumatology, comorbid infections (CIs) have a great impact on morbidity and mortality, in systemic connective tissue diseases in particular. In this connection, much attention is given to the intense introduction of different vaccines into

Externí odkaz: https://doaj.org/article/4ce8218ea4f446beaa354bbaf584c81b

BIOLOGICAL THERAPY AND INFECTION IN RHEUMATOID ARTHRITIS PATIENTS: MODERN ASPECTS

Autor: B. S. BELOV, M. S. NAUMTSEVA, G. M. TARASOVA, D. V. BUKHANOVA

Publikováno v: Медицинский совет, Vol 0, Iss 11, Pp 106-116 (2016)

In the recent decades rheumatology has been witnessing the marked progress associated with introduction into clinical practice of gene engineering biological drugs. At the same time use of these drugs is associated with the increasing risk of develop

Externí odkaz: https://doaj.org/article/8e28583738bc4d32997947b20044aa2d

TARGETED THERAPY AND INFECTIONS IN RHEUMATIC DISEASES

Autor: B. S. Belov, M. S. Naumtseva, G. M. Tarasova, D. V. Bukhanova

Publikováno v: Современная ревматология, Vol 10, Iss 4, Pp 4-15 (2016)

In the past decade, rheumatology has shown clear progress in the practical introduction of biological agents (BAs) and targeted sintetic anti-inflammatory agents. At the same time, the use of these agents is associated with an increasing risk for inf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6875482d56d44285e0f1ca5aea244fdb
https://mrj.ima-press.net/mrj/article/view/712

IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF A TWO-YEAR FOLLOW-UP STUDY

Autor: M. S. Naumtseva, B. S. Belov, E. N. Aleksandrova, G. M. Tarasova, A. A. Novikov, D. E. Karateev, E. L. Luchikhina, M. V. Cherkasova, Yu. V. Muravyev

Publikováno v: Naučno-Praktičeskaâ Revmatologiâ, Vol 54, Iss 6, Pp 674-680 (2016)
Naučno-Praktičeskaâ Revmatologiâ, Vol 54, Iss 6, Pp 674-680 (2017)
Научно-практическая ревматология, Vol 54, Iss 6, Pp 674-680 (2017)

Objective: to investigate the immunogenicity, safety, and clinical efficacy of 23-valent polysaccharide pneumococcal vaccine in patients with rheumatoid arthritis (RA) during a two-year follow-up study.Subjects and methods. The prospective open-label

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da98c60b5f15ba8a84033e7ddb54361
http://rsp.ima-press.net/rsp/article/view/2322

VACCINATION IN RHEUMATOLOGY: CURRENT ASPECTS

Autor: B. S. Belov, M. S. Naumtseva, G. M. Tarasova, M. V. Polyanskaya

Publikováno v: Научно-практическая ревматология, Vol 52, Iss 6, Pp 660-668 (2014)

Infectious diseases still remain a serious social and medical problem. The importance of comorbid infections in rheumatology has increased substantially in recent years, particularly due to the clinical introduction of biologicals. The investigation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ba3af665abfe48135b05fc120000135
https://rsp.mediar-press.net/rsp/article/view/2012